A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain

被引:80
作者
Callén, E
Casado, JA
Tischkowitz, MD
Bueren, JA
Creus, A
Marcos, R
Dasí, A
Estella, JM
Muñoz, A
Ortega, JJ
de Winter, J
Joenje, H
Schindler, D
Hanenberg, H
Hodgson, SV
Mathew, CG
Surrallés, J
机构
[1] Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Mutagenesis, E-08193 Barcelona, Spain
[2] Hosp Materno Infantil Vall Hebron, Barcelona, Spain
[3] Fdn Marcelino Botin, CIEMAT, Madrid, Spain
[4] Hosp Ramon y Cajal, E-28034 Madrid, Spain
[5] Hosp Univ la Fe, Valencia, Spain
[6] Hosp Sant Joan de Deu, Esplugues, Spain
[7] Univ Wurzburg, Wurzburg, Germany
[8] Univ Dusseldorf, D-4000 Dusseldorf, Germany
[9] Free Univ Amsterdam, Amsterdam, Netherlands
[10] Guys Kings & St Thomas Sch Med, Dept Med & Mol Genet, London, England
关键词
D O I
10.1182/blood-2004-07-2588
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fanconi anemia (FA) is a genetic disease characterized by bone marrow failure and cancer predisposition. Here we have identified Spanish Gypsies as the ethnic group with the world's highest prevalence of FA (carrier frequency of 1/64-1/70). DNA sequencing of the FANCA gene in 8 unrelated Spanish Gypsy FA families after retroviral subtyping revealed a homozygous FANCA mutation (295C>T) leading to FANCA truncation and FA pathway disruption. This mutation appeared specific for Spanish Gypsies as it is not found in other Gypsy patients with FA from Hungary, Germany, Slovakia, and Ireland. Haplotype analysis showed that Spanish Gypsy patients all share the same haplotype. Our data thus suggest that the high incidence of FA among Spanish Gypsies is due to an ancestral founder mutation in FANCA that originated in Spain less than 600 years ago. The high carrier frequency makes the Spanish Gypsies a population model to study FA heterozygote mutations in cancer.
引用
收藏
页码:1946 / 1949
页数:4
相关论文
共 22 条
[1]  
[Anonymous], 1973, GYPSIES
[2]  
BOGLIOLO M, IN PRESS DNA REPAIR
[3]   Quantitative PCR analysis reveals a high incidence of large intragenic deletions in the FANCA gene in Spanish Fanconi anemia patients [J].
Callén, E ;
Tischkowitz, MD ;
Creus, A ;
Marcos, R ;
Bueren, JA ;
Casado, JA ;
Mathew, CG ;
Surrallés, J .
CYTOGENETIC AND GENOME RESEARCH, 2004, 104 (1-4) :341-345
[4]   Relationship between chromosome fragility, aneuploidy and severity of the haematological disease in Fanconi anaemia [J].
Callén, E ;
Ramírez, MJ ;
Creus, A ;
Marcos, R ;
Ortega, JJ ;
Olivé, T ;
Badell, I ;
Surrallés, J .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2002, 504 (1-2) :75-83
[5]   The clastogenic response of the 1q12 heterochromatic region to DNA cross-linking agents is independent of the Fanconi anaemia pathway [J].
Callén, E ;
Ramírez, MJ ;
Creus, A ;
Marcos, R ;
Frias, S ;
Molina, B ;
Badell, I ;
Olivé, T ;
Ortega, JJ ;
Surrallés, J .
CARCINOGENESIS, 2002, 23 (08) :1267-1271
[6]   Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia [J].
Callén, E ;
Samper, E ;
Ramírez, MJ ;
Creus, A ;
Marcos, R ;
Ortega, JJ ;
Olivé, T ;
Badell, I ;
Blasco, MA ;
Surrallés, J .
HUMAN MOLECULAR GENETICS, 2002, 11 (04) :439-444
[7]   The Fanconi road to cancer [J].
D'Andrea, AD .
GENES & DEVELOPMENT, 2003, 17 (16) :1933-1936
[8]   Interaction of the fanconi anemia proteins and BRCA1 in a common pathway [J].
Garcia-Higuera, I ;
Taniguchi, T ;
Ganesan, S ;
Meyn, MS ;
Timmers, C ;
Hejna, J ;
Grompe, M ;
D'Andrea, AD .
MOLECULAR CELL, 2001, 7 (02) :249-262
[9]   Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool [J].
Hanenberg, H ;
Batish, SD ;
Pollok, KE ;
Vieten, L ;
Verlander, PC ;
Leurs, C ;
Cooper, RJ ;
Göttsche, K ;
Haneline, L ;
Clapp, DW ;
Lobitz, S ;
Williams, DA ;
Auerbachc, AD .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (05) :410-420
[10]   The emerging genetic and molecular basis of Fanconi anaemia [J].
Joenje, H ;
Patel, KJ .
NATURE REVIEWS GENETICS, 2001, 2 (06) :446-457